Neue Aspekte in der Chemotherapie des fortgeschrittenen Magenkarzinoms
作者： P. Preusser , H. Wilke , W. Achterrath , U. Fink , H.-J Meyer
DOI: 10.1007/978-3-642-73427-4_23
关键词:
摘要: Das Magenkarzinom steht in der Todesursachenstatistik malignen Neoplasien Bundesrepublik Deutschland an zweiter Stelle. Jahrlich werden 28 Sterbefalle auf 100000 Einwohner registriert [39].
springer.com
sci-hub.st 参考文章(67)
G. Falkson, HALOGENATED PYRIMIDINES AS RADIOPOTENTIATORS IN THE TREATMENT OF STOMACH CANCER Progr. Biochem. Pharmacol.. ,(1965)
Stephen K. Carter, Eli Glatstein, Robert B. Livingston, Principles of cancer treatment McGraw-Hill. ,(1982)
Clinical Evaluation of Antitumor Therapy Springer US. ,(1987) , 10.1007/978-1-4613-2317-4
Steven A. Rosenberg, Vincent T. DeVita, Samuel Hellman, Cancer : Principles and Practice of Oncology ,(1982)
F J Panettiere, C Haas, B McDonald, J J Costanzi, R W Talley, J Athens, N Oishi, L K Heilbrun, T T Chen, Drug combinations in the treatment of gastric adenocarcinoma: a randomized Southwest Oncology Group study. Journal of Clinical Oncology. ,vol. 2, pp. 420- 424 ,(1984) , 10.1200/JCO.1984.2.5.420
C G Moertel, J Rubin, M J O'Connell, A J Schutt, H S Wieand, A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas. Journal of Clinical Oncology. ,vol. 4, pp. 1053- 1057 ,(1986) , 10.1200/JCO.1986.4.7.1053
G. Scherdin, M. Garbrecht, U. Müllerleile, D. K. Hossfeld, Polychemotherapy with methotrexate in medium dose range, 5-fluorouracil and adriamycin in advanced gastric carcinoma Journal of Cancer Research and Clinical Oncology. ,vol. 111, ,(1986) , 10.1007/BF02580109
Oscar Serlin, Jerry S. Wolkoff, Jose M. Amadeo, Robert J. Keehn, Use of 5-fluorodeoxyuridine (FUDR) as an adjuvant to the surgical management of carcinoma of the stomach Cancer. ,vol. 24, pp. 223- 228 ,(1969) , 10.1002/1097-0142(196908)24:2<223::AID-CNCR2820240203>3.0.CO;2-U
John S. Kovach, Charles G. Moertel, Alan J. Schutt, Richard G. Hahn, Richard J. Reitemeier, A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancer Cancer. ,vol. 33, pp. 563- 567 ,(1974) , 10.1002/1097-0142(197402)33:2<563::AID-CNCR2820330235>3.0.CO;2-K
K. Kolarić, V. Potrebica, M. Stanovnik, Controlled phase III clinical study of 4-epi-doxorubicin + 5-fluorouracil versus 5-fluorouracil alone in metastatic gastric and rectosigmoid cancer. Oncology. ,vol. 43, pp. 73- 77 ,(1986) , 10.1159/000226337